Why Covid elimination remains the best game-plan
Here in Aotearoa, we’re playing Covid-19 in “elimination” mode. Some countries are trying “suppression” mode, while others are running with...
New research provides hope for drug treatment to slow neurodegenerative disease
Scientists have found a new drug treatment that can slow the progression of neurodegenerative disease in mice.
Astronomer Lamiya Mowla breaks down ‘remarkable’ new Webb telescope image
Astronomers have revealed the latest deep-field image from NASA’s James Webb Space Telescope, featuring never-before-seen details in a region of space named Pandora’s Cluster.
New Centre for Water and Spatial Science opens at UWA
A new Centre for Water and Spatial Science has been formally opened at The University of Western Australia, bringing together world-class experts from UWA’s Schools of Agriculture and Environment...
Smoking associated with increased risk of COVID-19 symptoms
Smoking is associated with an increased risk of COVID-19 symptoms and smokers are more likely to attend hospital than non-smokers, a study has found.
PowerHouseGames returns to The University of Warwick for third consecutive year
The third PowerHouseGames was held at the Sports and Wellness Hub at The University of Warwick on Thursday 27 February 2025, showcasing inclusive sport.
Manipulating light at nanoscale for increased photon upconversion
NUS researchers led by Professor Liu Xiaogang from the NUS Department of Chemistry, in collaboration with Dr Gianluigi Zito from the National Research Council of Italy...
Hormone found to regulate mothers’ behaviour
University of Otago researchers have discovered a new function for the hormone prolactin – it limits a new mum’s investment in aggressive behaviour and instead focusses them on interacting with their babies.
‘Good’ fats and inflammation: more complex than first thought
Omega-3 fatty acids, popularly believed to reduce inflammation in the body, appear to increase certain inflammatory markers, researchers have found.
Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use
Patients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumatoid arthritis or fibromyalgia potentially at risk, suggest researchers at The University of Manchester.
